Tõnis Tasa

The paper develops a polygenic risk score-based pipeline to provide personalized recommendations for melanoma prevention by integrating genetic risk with health behavior.

This paper constructs a polygenic risk score (PRS) model for prostate cancer risk prediction and develops personalized screening recommendations using population-specific data.

This paper develops a sex-specific polygenic risk score model for colorectal cancer screening, showing it can stratify risk and inform individualized screening recommendations.

The paper revalidates a polygenic risk score (PRS) model for breast cancer risk prediction and develops a pipeline for individualized screening recommendations using population-specific data.

The paper evaluates vancomycin population pharmacokinetic models in neonates using external data, finding wide variation in predictive performance and low attainment of therapeutic targets.